Propiedad y actividad de insiders de Seres Therapeutics, Inc. (MCRB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $4.21 |
| Capitalización | $41M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $54.5M | $36.1M | $85.8M | $65.1M | $116.0M | $180.0M | $163.0M | $128.0M | $30.8M | $45.8M |
| Inversiones a Corto | $138.7M | $113.9M | 0 | $29.7M | $137.6M | $110.7M | $18.3M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $1.8M | $9.4M | 0 | 0 | 0 | $4.8M | $360000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $29.6M | 0 | 0 |
| Activos Corrientes | $198.4M | $155.1M | $92.7M | $100.2M | $268.8M | $303.6M | $194.8M | $175.4M | $38.7M | $49.4M |
| Inmovilizado Material | $36.1M | $32.9M | $26.3M | $30.9M | $22.9M | $36.1M | $134.0M | $108.0M | $92.4M | $80.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $272.6M | $189.5M | $120.5M | $132.4M | $342.9M | $354.9M | $348.8M | $358.6M | $139.8M | $138.2M |
| Cuentas por Pagar | $7.6M | $7.0M | $6.4M | $4.9M | $4.0M | $13.7M | $17.4M | $3.6M | $4.1M | $1.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $454000 | 0 | $456000 | 0 | 0 | $10.4M |
| Pasivos Corrientes | $30.5M | $31.6M | $42.0M | $46.0M | $46.4M | $82.3M | $85.6M | $98.7M | $41.2M | $19.3M |
| Deuda a Largo | 0 | 0 | 0 | $24.6M | $24.6M | $24.6M | $50.6M | $101.5M | 0 | 0 |
| Pasivos Totales | $140.0M | $128.8M | $168.5M | $180.8M | $168.2M | $223.4M | $338.0M | $403.5M | $126.0M | $94.0M |
| Reservas | -$174.2M | -$263.6M | -$389.4M | -$459.6M | -$548.8M | -$614.4M | -$864.5M | -$978.2M | -$978.1M | -$972.4M |
| Patrimonio Neto | $132.6M | $60.7M | -$48.0M | -$48.3M | $174.8M | $131.5M | $10.8M | -$44.9M | $13.8M | $44.2M |
| Deuda Total | $10.7M | $9.0M | $7.2M | $44.8M | $40.8M | $49.2M | $162.6M | $198.8M | $91.6M | $83.0M |
| Deuda Neta | -$182.5M | -$141.0M | -$78.6M | -$50.0M | -$212.8M | -$241.5M | -$18.8M | $70.8M | $60.8M | $37.2M |
| Capital Circulante | $167.9M | $123.5M | $50.6M | $54.2M | $222.4M | $221.4M | $109.2M | $76.8M | -$2.5M | $30.1M |
Salud financiera
| Deuda / Patrimonio | 1.64 |
| Ratio corriente | 2.11 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -10.99 |
Rentabilidad
| Rentabilidad sobre capital | -60.32% |
| Rentabilidad sobre capital invertido | -89.99% |
| Rentabilidad sobre activos | -22.11% |
| Margen bruto | 82.58% |
| Margen operativo | -4462.77% |
| Margen neto | -1192.94% |
Empresas relacionadas: ABOS · ACTU · APLT · CGTX · HURA · INO · IRD
Explorar sector: Healthcare · Biotechnology
Más secciones de MCRB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones